Fmr LLC Acquires 699,728 Shares of HealthEquity, Inc. (HQY)
Fmr LLC increased its holdings in shares of HealthEquity, Inc. (NASDAQ:HQY) by 45.6% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 2,235,150 shares of the company’s stock after acquiring an additional 699,728 shares during the period. Fmr LLC owned about 3.73% of HealthEquity worth $111,378,000 at the end of the most recent reporting period.
Other institutional investors have also modified their holdings of the company. Vanguard Group Inc. boosted its position in shares of HealthEquity by 6.2% during the 1st quarter. Vanguard Group Inc. now owns 4,115,237 shares of the company’s stock valued at $174,691,000 after acquiring an additional 240,136 shares in the last quarter. Paloma Partners Management Co acquired a new stake in shares of HealthEquity during the 1st quarter valued at about $503,000. First Trust Advisors LP boosted its position in shares of HealthEquity by 17.0% during the 2nd quarter. First Trust Advisors LP now owns 94,283 shares of the company’s stock valued at $4,698,000 after acquiring an additional 13,676 shares in the last quarter. Royce & Associates LP boosted its position in shares of HealthEquity by 18.0% during the 2nd quarter. Royce & Associates LP now owns 139,200 shares of the company’s stock valued at $6,936,000 after acquiring an additional 21,200 shares in the last quarter. Finally, Russell Investments Group Ltd. acquired a new stake in shares of HealthEquity during the 2nd quarter valued at about $1,362,000. Institutional investors and hedge funds own 90.97% of the company’s stock.
ILLEGAL ACTIVITY WARNING: This news story was posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this news story on another website, it was stolen and republished in violation of U.S. & international copyright laws. The correct version of this news story can be read at https://www.thecerbatgem.com/2017/10/09/fmr-llc-acquires-699728-shares-of-healthequity-inc-hqy.html.
In other HealthEquity news, insider Stephen Neeleman sold 8,500 shares of the stock in a transaction dated Monday, July 17th. The shares were sold at an average price of $50.83, for a total transaction of $432,055.00. Following the sale, the insider now directly owns 1,000 shares in the company, valued at $50,830. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, VP Darcy G. Mott sold 9,500 shares of the stock in a transaction dated Wednesday, September 20th. The stock was sold at an average price of $46.79, for a total transaction of $444,505.00. Following the sale, the vice president now owns 87,500 shares in the company, valued at $4,094,125. The disclosure for this sale can be found here. Insiders have sold 1,153,704 shares of company stock worth $58,570,360 over the last quarter. Corporate insiders own 19.00% of the company’s stock.
Several analysts have recently weighed in on the stock. BidaskClub upgraded shares of HealthEquity from a “sell” rating to a “hold” rating in a research report on Thursday, September 28th. Oppenheimer Holdings, Inc. reiterated a “buy” rating and set a $61.00 target price on shares of HealthEquity in a research report on Wednesday, September 6th. Cantor Fitzgerald reiterated a “buy” rating and set a $56.00 target price on shares of HealthEquity in a research report on Tuesday, August 29th. Robert W. Baird reiterated a “hold” rating on shares of HealthEquity in a research report on Thursday, September 21st. Finally, Zacks Investment Research lowered shares of HealthEquity from a “buy” rating to a “hold” rating in a research report on Friday, August 4th. Three equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. The stock has an average rating of “Buy” and an average price target of $56.50.
HealthEquity, Inc. (HQY) opened at 51.91 on Monday. The firm has a market capitalization of $3.14 billion, a price-to-earnings ratio of 77.02 and a beta of 1.80. HealthEquity, Inc. has a 52-week low of $30.34 and a 52-week high of $54.95. The firm has a 50-day moving average of $45.91 and a 200-day moving average of $46.52.
HealthEquity (NASDAQ:HQY) last announced its quarterly earnings data on Tuesday, September 5th. The company reported $0.27 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.14 by $0.13. The firm had revenue of $56.90 million for the quarter, compared to the consensus estimate of $55.66 million. HealthEquity had a net margin of 20.27% and a return on equity of 13.93%. The business’s revenue for the quarter was up 28.7% on a year-over-year basis. During the same period in the prior year, the company posted $0.16 earnings per share. On average, equities research analysts forecast that HealthEquity, Inc. will post $0.71 EPS for the current fiscal year.
HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.
Receive News & Stock Ratings for HealthEquity Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity Inc. and related stocks with our FREE daily email newsletter.